...
首页> 外文期刊>Protein Science: A Publication of the Protein Society >Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors.
【24h】

Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors.

机译:结核分枝杆菌S-腺苷-L-高半胱氨酸水解酶与底物和抑制剂的三元复合物的晶体结构。

获取原文
获取原文并翻译 | 示例

摘要

S-adenosylhomocysteine hydrolase (SAHH) is a ubiquitous enzyme that plays a central role in methylation-based processes by maintaining the intracellular balance between S-adenosylhomocysteine (SAH) and S-adenosylmethionine. We report the first prokaryotic crystal structure of SAHH, from Mycobacterium tuberculosis (Mtb), in complex with adenosine (ADO) and nicotinamide adenine dinucleotide. Structures of complexes with three inhibitors are also reported: 3'-keto aristeromycin (ARI), 2-fluoroadenosine, and 3-deazaadenosine. The ARI complex is the first reported structure of SAHH complexed with this inhibitor, and confirms the oxidation of the 3' hydroxyl to a planar keto group, consistent with its prediction as a mechanism-based inhibitor. We demonstrate the in vivo enzyme inhibition activity of the three inhibitors and also show that 2-fluoradenosine has bactericidal activity. While most of the residues lining the ADO-binding pocket are identical between Mtb and human SAHH, less is known about the binding mode of the homocysteine (HCY) appendage of the full substrate. We report the 2.0 A resolution structure of the complex of SAHH cocrystallized with SAH. The most striking change in the structure is that binding of HCY forces a rotation of His363 around the backbone to flip out of contact with the 5' hydroxyl of the ADO and opens access to a nearby channel that leads to the surface. This complex suggests that His363 acts as a switch that opens up to permit binding of substrate, then closes down after release of the cleaved HCY. Differences in the entrance to this access channel between human and Mtb SAHH are identified.
机译:S-腺苷同型半胱氨酸水解酶(SAHH)是一种普遍存在的酶,通过维持S-腺苷同型半胱氨酸(SAH)和S-腺苷甲硫氨酸之间的细胞内平衡,在基于甲基化的过程中发挥核心作用。我们报告SAHH的第一个原核晶体结构,从结核分枝杆菌(Mtb),与腺苷(ADO)和烟酰胺腺嘌呤二核苷酸复合。还报道了与三种抑制剂的复合物的结构:3'-酮阿霉素(ARI),2-氟腺苷和3-脱氮杂腺苷。 ARI配合物是SAHH首次与该抑制剂配合的结构,并证实3'羟基氧化为平面酮基,与其作为基于机理的抑制剂的预测相符。我们证明了三种抑制剂的体内酶抑制活性,并且还表明2-氟腺苷具有杀菌活性。虽然在Mtb和人SAHH之间衬着ADO结合袋的大多数残基是相同的,但对整个底物的同型半胱氨酸(HCY)附肢的结合方式知之甚少。我们报告了与SAH共结晶的SAHH配合物的2.0 A拆分结构。结构上最引人注目的变化是,HCY的结合迫使His363围绕骨架旋转,从而翻转脱离与ADO的5'羟基的接触,并打开了通向表面的附近通道的通道。该复合物表明His363充当开关,其打开以允许底物结合,然后在裂解的HCY释放后关闭。确定了人与Mtb SAHH在此访问通道入口的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号